Agilent Bio SEC-5 for Analysis of Virus-Like Particles (VLP)

Consumables Workflow Ordering Guide Aggregate Analysis of Adeno-Associated Viruses and Virus-Like Particles in Biopharma by Liquid Chromatography Adeno-associated viruses (AAVs) and virus-like particles (VLPs) are emerging biotherapeutic molecules with exciting potential in the vaccine, cell, and gene therapy spaces. AAVs…

Application Note Biopharma/Pharma Robust Wide Pore Size Exclusion Columns for Virus-Like Particles (VLPs) Analysis Using Agilent AdvanceBio SEC column technology Authors Abstract Charu Kumar, Ta-Chen Wei, Andrew Coffey, and Anne Blackwell Agilent Technologies, Inc. Aggregate analysis of VLPs is a…

High-Speed, High-Resolution Aggregate Analysis of Ultralarge Biotherapeutics Agilent AdvanceBio SEC 2.7 µm columns with 500 and 1000 Å pores Optimal pore sizes for your ultralarge biotherapeutics analyses Adeno-associated viruses (AAV), virus-like particles (VLP), oligonucleotides, and lipid nanoparticles (LNP) represent the…

Aggregate Analysis of Biotherapeutics Agilent size exclusion columns Accurately determine biomolecule aggregation and fragmentation Size exclusion chromatography (SEC) is a technique for separating proteins, oligonucleotides, and other complex biopolymers by size, using aqueous eluents. It is an essential tool for…